MTOR and breast carcinoma: Given the phosphorylation of ER, the dynamic activation of the ER membrane complex and the role of mTOR in AMPK and insulin signalling described earlier (Figures 3J and 4C) this phosphorylation site may present a key step in the cellular response to progesterone in breast cancer.